PDB Short entry for 1APM HEADER TRANSFERASE(PHOSPHOTRANSFERASE) 18-JAN-93 1APM TITLE 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF TITLE 2 CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND TITLE 3 DETERGENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE; COMPND 3 CHAIN: E; COMPND 4 EC: 2.7.1.37; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PEPTIDE INHIBITOR PKI(5-24); COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 7 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 8 ORGANISM_TAXID: 10090 KEYWDS TRANSFERASE(PHOSPHOTRANSFERASE) EXPDTA X-RAY DIFFRACTION AUTHOR D.R.KNIGHTON,S.M.BELL,J.ZHENG,L.F.TENEYCK,N.-H.XUONG,S.S.TAYLOR, AUTHOR 2 J.M.SOWADSKI REVDAT 5 03-NOV-21 1APM 1 SEQADV REVDAT 4 14-AUG-19 1APM 1 REMARK REVDAT 3 17-JUL-19 1APM 1 REMARK LINK REVDAT 2 24-FEB-09 1APM 1 VERSN REVDAT 1 15-APR-93 1APM 0 JRNL AUTH D.R.KNIGHTON,S.M.BELL,J.ZHENG,L.F.TEN EYCK,N.H.XUONG, JRNL AUTH 2 S.S.TAYLOR,J.M.SOWADSKI JRNL TITL 2.0 A REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF JRNL TITL 2 CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE JRNL TITL 3 INHIBITOR AND DETERGENT. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 49 357 1993 JRNL REFN ISSN 0907-4449 JRNL PMID 15299526 JRNL DOI 10.1107/S0907444993000502 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.ZHENG,D.R.KNIGHTON,L.F.TENEYCK,R.KARLSSON,N.-H.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,J.M.SOWADSKI REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE COMPLEXED WITH MG/ATP AND PEPTIDE INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 32 2154 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.R.KNIGHTON,J.ZHENG,L.F.TENEYCK,V.A.ASHFORD,N.-H.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,J.M.SOWADSKI REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC REMARK 1 TITL 2 ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN KINASE REMARK 1 REF SCIENCE V. 253 407 1991 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.R.KNIGHTON,J.ZHENG,L.F.TENEYCK,N.-H.XUONG,S.S.TAYLOR, REMARK 1 AUTH 2 J.M.SOWADSKI REMARK 1 TITL STRUCTURE OF A PEPTIDE INHIBITOR BOUND TO THE CATALYTIC REMARK 1 TITL 2 SUBUNIT OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN REMARK 1 TITL 3 KINASE REMARK 1 REF SCIENCE V. 253 414 1991 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 4 REMARK 1 AUTH L.W.SLICE,S.S.TAYLOR REMARK 1 TITL EXPRESSION OF THE CATALYTIC SUBUNIT OF C/AMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE IN ESCHERICHIA COLI REMARK 1 REF J.BIOL.CHEM. V. 264 20940 1989 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2846 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES E 51-E 55, E 319-E 322, AND I 23-I 24 HAVE WEAK REMARK 3 BACKBONE ELECTRON DENSITY. REMARK 4 REMARK 4 1APM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171101. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.92000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.50500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.88000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.50500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.92000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.88000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY E 1 REMARK 465 ASN E 2 REMARK 465 ALA E 3 REMARK 465 ALA E 4 REMARK 465 ALA E 5 REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN E 12 CG CD OE1 NE2 REMARK 470 LYS E 16 CG CD CE NZ REMARK 470 GLU E 17 CG CD OE1 OE2 REMARK 470 LYS E 21 CG CD CE NZ REMARK 470 GLU E 24 CG CD OE1 OE2 REMARK 470 ASP E 25 CG OD1 OD2 REMARK 470 LYS E 28 CE NZ REMARK 470 SER E 34 OG REMARK 470 GLN E 39 CG CD OE1 NE2 REMARK 470 ASP E 41 CG OD1 OD2 REMARK 470 ARG E 45 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 63 CD CE NZ REMARK 470 GLU E 64 CG CD OE1 OE2 REMARK 470 LYS E 78 CD CE NZ REMARK 470 LYS E 83 CD CE NZ REMARK 470 LYS E 105 CD CE NZ REMARK 470 GLU E 121 CG CD OE1 OE2 REMARK 470 GLN E 176 CG CD OE1 NE2 REMARK 470 GLN E 177 CG CD OE1 NE2 REMARK 470 LYS E 213 CG CD CE NZ REMARK 470 LYS E 217 CG CD CE NZ REMARK 470 LYS E 249 CG CD CE NZ REMARK 470 LYS E 254 CG CD CE NZ REMARK 470 ARG E 256 CD NE CZ NH1 NH2 REMARK 470 LYS E 266 CG CD CE NZ REMARK 470 ARG E 270 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 279 CG CD CE NZ REMARK 470 LYS E 285 CG CD CE NZ REMARK 470 GLU E 311 CG CD OE1 OE2 REMARK 470 LYS E 317 CG CD CE NZ REMARK 470 LYS E 319 CG CD CE NZ REMARK 470 GLU E 331 CG CD OE1 OE2 REMARK 470 GLU E 333 CG CD OE1 OE2 REMARK 470 GLU E 334 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU E 13 CD GLU E 13 OE1 0.076 REMARK 500 GLU E 140 CD GLU E 140 OE2 0.074 REMARK 500 GLU E 230 CD GLU E 230 OE1 0.068 REMARK 500 GLU E 341 CD GLU E 341 OE2 0.067 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP E 44 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 VAL E 60 CA - CB - CG2 ANGL. DEV. = 9.4 DEGREES REMARK 500 ASP E 75 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP E 75 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP E 112 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ARG E 134 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG E 134 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ASP E 161 CB - CG - OD1 ANGL. DEV. = -6.9 DEGREES REMARK 500 ASP E 161 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP E 184 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP E 220 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP E 220 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 TYR E 247 CB - CG - CD2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ASP E 264 CB - CG - OD1 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP E 267 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP E 267 CB - CG - OD2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP E 290 CB - CG - OD1 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP E 301 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP E 323 CB - CG - OD1 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP E 329 CB - CG - OD1 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP I 24 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE E 46 -62.66 -93.81 REMARK 500 ASN E 99 101.93 -166.19 REMARK 500 ARG E 165 -2.38 71.67 REMARK 500 LYS E 168 149.32 178.15 REMARK 500 ASP E 184 88.79 62.58 REMARK 500 ASN E 216 -162.25 -128.97 REMARK 500 LEU E 273 41.26 -85.27 REMARK 500 HIS I 23 -23.40 -147.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 INHIBITOR RESIDUE NUMBERING CORRESPONDS TO NUMBERS FROM REMARK 600 THE SEQUENCE OF THE LARGER NATURALLY OCCURRING PKI PROTEIN REMARK 600 OF WHICH THE INHIBITOR IS A SYNTHETIC FRAGMENT. REMARK 600 REMARK 600 THE MODEL HAS AN N-OCTANE RESIDUE (OCT) THAT IS USED TO REMARK 600 MODEL THE THE ORDERED PART OF A MEGA-8 (OCTANOYL-N- REMARK 600 METHYLGLUCAMIDE) DETERGENT MOLECULE OBSERVED NEAR THE REMARK 600 N-TERMINAL HELIX. DBREF 1APM E 1 350 UNP P05132 KAPCA_MOUSE 1 350 DBREF 1APM I 5 24 UNP P63248 IPKA_MOUSE 5 24 SEQADV 1APM ALA E 139 UNP P05132 SER 139 ENGINEERED MUTATION SEQRES 1 E 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN GLU SEQRES 2 E 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 E 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 E 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 E 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 E 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 E 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 E 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 E 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 E 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 E 350 HIS LEU ARG ARG ILE GLY ARG PHE ALA GLU PRO HIS ALA SEQRES 12 E 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 E 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 E 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 E 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 E 350 TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 E 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 E 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 E 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 E 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 E 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 E 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 E 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 E 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 E 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 E 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 E 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 1APM SEP E 10 SER PHOSPHOSERINE MODRES 1APM TPO E 197 THR PHOSPHOTHREONINE MODRES 1APM SEP E 338 SER PHOSPHOSERINE HET SEP E 10 10 HET TPO E 197 11 HET SEP E 338 10 HET OCT E 354 8 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM OCT N-OCTANE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 OCT C8 H18 FORMUL 4 HOH *207(H2 O) HELIX 1 A GLU E 11 GLU E 31 1 21 HELIX 2 AB LEU E 40 GLN E 42 5NOT NOTED IN REF 2 3 HELIX 3 B LYS E 76 LYS E 81 1 6 HELIX 4 C ILE E 85 ALA E 97 1 13 HELIX 5 D MET E 128 ILE E 135 1 8 HELIX 6 E GLU E 140 SER E 159 1 20 HELIX 7 EF0 PRO E 169 ASN E 171 5NOT NOTED IN REF 2 3 HELIX 8 EF1 PRO E 202 TYR E 204 5NOT NOTED IN REF 2 3 HELIX 9 EF2 PRO E 207 ILE E 210 1NOT NOTED IN REF 2 4 HELIX 10 F ALA E 218 ALA E 233 1 16 HELIX 11 G PRO E 243 SER E 252 1 10 HELIX 12 H SER E 263 LEU E 272 1 10 HELIX 13 I ASN E 289 LYS E 292 1 4 HELIX 14 IJ LYS E 295 PHE E 297 5NOT NOTED IN REF 2 3 HELIX 15 J TRP E 302 GLN E 307 1 6 HELIX 16 IA THR I 6 ALA I 12 1INHIBITOR N-TERMINAL HELIX 7 SHEET 1 A 5 PHE E 43 THR E 51 0 SHEET 2 A 5 GLY E 55 HIS E 62 -1 SHEET 3 A 5 HIS E 68 ASP E 75 -1 SHEET 4 A 5 ASN E 115 GLU E 121 -1 SHEET 5 A 5 LEU E 106 LYS E 111 -1 SHEET 1 B 2 LEU E 162 ILE E 163 0 SHEET 2 B 2 LEU E 172 ILE E 174 -1 SHEET 1 C 2 ILE E 180 VAL E 182 0 SHEET 2 C 2 LYS E 189 ARG E 190 -1 LINK C SEP E 10 N GLU E 11 1555 1555 1.34 LINK C TRP E 196 N TPO E 197 1555 1555 1.31 LINK C TPO E 197 N LEU E 198 1555 1555 1.32 LINK C VAL E 337 N SEP E 338 1555 1555 1.33 LINK C SEP E 338 N ILE E 339 1555 1555 1.34 CRYST1 73.840 75.760 81.010 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013543 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013200 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012344 0.00000 HETATM 1 N SEP E 10 -7.153 -20.816 -14.915 1.00 36.59 N HETATM 2 CA SEP E 10 -8.344 -20.050 -14.482 1.00 34.88 C HETATM 3 CB SEP E 10 -9.516 -20.906 -13.949 1.00100.00 C HETATM 4 OG SEP E 10 -10.760 -20.216 -14.040 1.00100.00 O HETATM 5 C SEP E 10 -7.992 -18.823 -13.599 1.00 43.48 C HETATM 6 O SEP E 10 -8.385 -17.670 -13.880 1.00 46.16 O HETATM 7 P SEP E 10 -12.192 -20.937 -13.799 1.00100.00 P HETATM 8 O1P SEP E 10 -12.854 -20.167 -12.708 1.00100.00 O HETATM 9 O2P SEP E 10 -12.444 -21.872 -14.958 1.00 51.82 O HETATM 10 O3P SEP E 10 -12.129 -21.747 -12.565 1.00100.00 O